NCT06822868View on ClinicalTrials.gov

A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

PHASE1RecruitingINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

February 10, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2026

Conditions

B-Cell Non-Hodgkin Lymphoma

Interventions

DRUG

CAR T cells

chimeric antigen receptor T cells

Trial Locations (1)

102200

RECRUITING

Beijing GoBroad Hospital, Beijing

All Listed Sponsors

lead

Kai Hu

OTHER